Scientific Program Unique
Opportunity: Thursday October 12 Cardiovascular Disease Risk reduction 9.00 – 9.40 Soy and cholesterol: yesterday, today and … tomorrow? - Prof. Cesare Sirtori, University of Milan, Italy 9.40 – 10.15 When to use soy protein or drug in children with familial hypercholesterolemia? - Prof. Kurt Widhalm, University of Vienna, Austria 10.15 – 10.50 Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hyperlipidemia - Dr. Cyril Kendall, St Michael’s Hospital, Toronto, Canada 10.50 – 11.20 Coffee Break kindly offered by SoyLife 11.20 - 11.55 Phytoestrogens and their fatty acid esters: could they have a role in antioxidant protection of lipoproteins? - Prof. Matti J. Tikkanen, University of Helsinki, Finland 11.55 - 12.30 Dietary isoflavones in the absence of soy protein reduce cardiovascular risk factors and this is possibly related to their chemical form in food - Prof. Ken Setchell, Children's Hospital & Medical Centre, Cincinnati, USA 12.30 - 13.45 Lunch kindly offered by Alpro Soyfoods Workshop 13.45 - 14.15 Soy foods warrant a larger role in Western diets - Prof. Mark Messina, Loma Linda University, USA - Workshop organised in cooperation with ENSA Role of soy in cognitive function 14.15 - 14.50 Proteomic identification of protein oxidations in mammalian brain attenuated by grape seed and soy polyphenols: implications for cognitive health - Prof. Helen Kim, University of Alabama at Birmingham, USA 14.50 - 15.25 The impact of soy isoflavones on cognitive function in younger and older women - Dr. Louise Dye, Leeds University, UK 15.25 – 15.55 Coffee/Tea Break kindly offered by SoyLife 15.55-16.30 Phosphatidylserine: a phospholipid with properties supporting mental and physical performance - Dr. Fred Brouns, Maastricht University, The Netherlands Future of soy in the European Diet 16.30 - 17.15 Interactive panel session including key scientific speakers of the conference Moderator: Nigel Duffin, Soya Protein Association, UK Soy health claims in Europe. Where are we now and tomorrow? - Dr. Janice Harland, HarlandHall, U.K. Soy position and perception in the European market – Dr. Jo Goossens, Giract, Switzerland Role of the industry in introducing Soy & Health promoting soy ingredients and products – Soy Industry representatives Friday October 13 Cancer prevention. Role of soy & isoflavones & other constituents 9.00 - 9.35 The effects of short-term oral high phytoestrogen supplementation in prostate cancer patients? - Prof. Herman Adlercreutz, University of Helsinki, Finland 9.35 - 10.10 Genetic investigations of postmenopausal women supporting the cancer protection effect of soy - Prof. Uwe Rohr, University of Vienna, Austria 10.10 - 10.45 Break 10.45 – 11.20 Lunasin, a novel cancer preventive soy peptide - Prof. Ben O. de Lumen, University of California, Berkeley, USA 11.20 - 11.55 Status of current human trials utilizing Bowman Birk Inhibitor concentrate Prof. Ann Kennedy, University of Pennsylvania, Philadelphia, USA 11.55 – 13.15 Lunch kindly offered by Cargill Soy & inflammation 13.15 - 13.50 Polyphenolic compounds and chronic inflammation: Mechanisms for the inhibition of the transcription factor NF-kB -Prof. Dirk Haller, Technical University of Munich, Germany Eye function 13.50 - 14.25 Potential role of isoflavones in the preservation of eye lens function in aging - Prof. Stephen Barnes, University of Alabama at Birmingham, USA 14.25 - 14.55 Break Hot flushes and osteoporosis 14.55 - 15.35 Skeletal effects of soy and isoflavones: A review - Prof. John Anderson, University of North Carolina, Chapel Hill, USA 15.35 - 16.10 Soyfoods and isoflavones for alleviating hot flushes - Prof. Mark Messina, Loma Linda University, USA Take home messages 16.10 - 16.25 Conference wrap-up: What have we learnt? International Scientific Advisory Board Prof. Mark Messina, University of Loma Linda, USA; Prof. Ken Setchell, Children's Hospital & Medical Centre, Cincinnati, USA; Prof. Stephen Barnes, University of Alabama at Birmingham, USA; Prof. Cesare Sirtori, University of Milan, Italy; Prof. Helmut Heseker, University of Paderborn, Germany; Prof. Hans Steinhart, University of Hamburg, Germany; Prof. Kurt Widhalm, Viena Medical University, Austria; Prof. Jean Daydé, ESA Purpan, France; Prof. Jean-Michel Lecerf, Institut Pasteur de Lille, France; Prof. Risto Santti, University of Turku, Finland; Prof. Ian Rowland, University of Ulster, Northern Ireland; Prof. Herman Adlercreutz, University of Helsinki, Finland; Prof. Jaak Janssens, European Cancer Prevention Organisation, Belgium |
